Proactive - Interviews for investors

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Sprintex Ltd (ASX:SIX).

The company has secured a significant A$17.5 million exclusive distribution agreement with Air End Repair Ltd in the United Kingdom.

This five-year agreement positions Air End Repair as the exclusive distributor of Sprintex G Series Blowers in the UK, with an initial order valued at A$125,750.

This deal comes hot on the heels of Sprintex’s three-year A$7.16 million agreement with Euroteck Environmental in India.

Combined with a previous agreement in Türkiye, these commitments bring Sprintex’s total global minimum order value to A$30 million.

The UK industrial air solutions market is valued at US$182 million in 2024, with a projected CAGR of 4.3%.

In India, the turbo blower market is worth US$100 million, growing at a CAGR of 8.8%.

Sprintex’s G Series Blowers aim to meet increasing demand for energy-efficient solutions in these dynamic regions.

Sprintex describes these agreements as transformative milestones, expanding its presence across Europe and Asia.

The partnerships leverage local expertise to drive adoption of energy-saving industrial solutions, further establishing Sprintex as a leader in innovative blower technology and delivering shareholder value.

#ProactiveInvestors #Sprintex #ASX #JusttheFacts #ExclusiveAgreements #IndustrialSolutions #EnergyEfficiency #UKMarket #IndiaMarket #GlobalExpansion #TurboBlowers #CleanTech #Sustainability #IndustrialEfficiency #ASXSIX #Innovation #GSeriesBlowers #ManufacturingGrowth #BusinessPartnership #GreenTechnology #AirEndRepair #Euroteck #GlobalLeadership

Artemis Resources Ltd (ASX:ARV, AIM:ARV, OTCQB:ARTTF) executive director George Ventouras talks with Proactive’s Tylah Tully about the company’s 2024 achievements and outlook for 2025.

Ventouras highlights key milestones, including the discovery of high-grade lithium with spodumene on its tenements earlier this year and renewed focus on the company’s gold projects, particularly regional exploration across its tenements.

Discussing the recent capital raise, Ventouras noted that the oversubscribed $4 million raise would fund drill testing of multiple targets early next year.

He emphasised the groundwork done to refine exploration areas and revealed drilling programs set for January through March 2025, targeting high-potential zones.

“The money is going to be spent in the ground, which is really exciting,” Ventouras said, pointing to significant upside across the company’s extensive Pilbara tenements.

Looking ahead, Ventouras outlined plans to advance gold exploration, particularly at high-grade Titan Prospect, while remaining open to opportunities amid anticipated M&A activity in the northwest Pilbara region.

#ProactiveInvestors #ArtemisResources #ASX #OTC #AIM #GoldExploration #LithiumDiscovery #CarlowResource #TitanProspect #ASX #MiningInvesting #Pilbara #LithiumBoom #CapitalRaise

Orthocell Ltd (ASX:OCC, OTC:ORHHF) chairman John Van Der Wielen talks with Proactive’s Tylah Tully about milestones achieved by the company this year and shared insights into its growth outlook for 2025r.

Van Der Wielen highlighted Orthocell’s focus on execution, emphasising clinical and regulatory successes for key products Striate+™ and Remplir™.

The company secured approvals in Singapore and is preparing for a significant market entry into the United States, including an FDA application for Remplir™.

Van Der Wielen noted, “Our biggest achievement has been focusing on products that generate revenue while expanding into new markets globally.”

Orthocell also achieved its first sales in Singapore following product clearance in October, reflecting strong commercial momentum.

Further regulatory submissions for the SmartGraf tendon repair product are pending with the TGA, targeting the global tendon repair market.

Van Der Wielen also discussed Orthocell’s share price growth, attributing the performance to tangible clinical outcomes and expanding revenue streams.

“This is no longer speculative,” he stated. “Our products are changing lives and being used in human bodies worldwide.”

Looking ahead, Orthocell plans to launch Striate+™ into Austria and Switzerland and advance Remplir™ in the US, setting up significant revenue growth into 2025.

#ProactiveInvestors #Orthocell #ASX #OTC #US #MedicalDevices #FDAApproval #StriatePlus #Remplir #Orthobiologics #TendonRepair #HealthcareInnovation #BiotechInvesting #ClinicalSuccess #ASX #Growth2024

Buru Energy Ltd (ASX:BRU, OTC:BRNGF) CEO Thomas Nador talks with Proactive’s Tylah Tully about the company's strategic initiatives and outlook for 2025.

Recently, Buru Energy announced a refocusing strategy to concentrate on its core assets, notably the development of the Rafael project and the potential restart of the Ungani oilfield.

Nador emphasised that the Rafael project was the most value-accretive opportunity in Buru's portfolio, with plans targeting a final investment decision by late 2025 and first gas production in the second half of 2027.

He stated, "Developing the Rafael project is the most value accretive opportunity the company has in its portfolio."

Additionally, Buru Energy is exploring alternative sales routes to recommence production from the Ungani Oilfield, aiming to reestablish revenue streams.

Looking ahead, the company plans to update investors on project partnerships, gas and liquids offtake agreements and subsidiary divestments in early 2025.

Nador concluded by wishing shareholders a safe and merry festive season, expressing optimism for the company's journey towards building a significant gas and liquids business in northwest Western Australia.

#ProactiveInvestors #BuruEnergy #ASX #OTC #RafaelProject #UnganiOilfield #EnergyDevelopment #WesternAustralia #OilAndGas #EnergyInvestment #CanningBasin

Proactive’s Tylah Tully provides the latest company cornerstone for Terra Metals Ltd (ASX:TM1, OTC:PNGZF).

The Australian exploration company is leveraging Western Australia's geology to expand its mineral portfolio.

Terra’s flagship Dante Project spans 650 square kilometres in the West Musgrave region and is geologically similar to South Africa's Bushveld Complex, renowned for its layered mafic intrusions.

Dante hosts copper-PGE sulphide reefs with thicknesses of 5–10 metres, supporting low-cost, open-cut mining prospects.

Reconnaissance drilling showed 39 out of 40 holes intersected mineralisation, with assays indicating copper, gold, PGEs, vanadium and titanium potential. Recent assays included significant results such as 5.8 metres at 0.34% copper and 0.80% vanadium.

The Onslow Copper-Gold Project in Pilbara has revealed high-grade silver, including 1 metre at 1,060 g/t silver, 0.23% copper and 0.99% tungsten, with an associated high-sulphidation epithermal system.

Meanwhile, at the Southern Cross Lithium Project in the Yilgarn, Terra has identified a 10-kilometre lithium anomaly.

Terra integrates ESG principles, maintaining relationships with Traditional Owners and promoting community development. This approach aids permitting and ensures alignment with local values.

#ProactiveInvestors #TerraMetals #ASX #CompanyCornerstones #MiningExploration #DanteProject #CopperMining #GoldExploration #PGEMinerals #Vanadium #Titanium #LithiumMining #BushveldComplex #MineralExploration #WesternAustralia #OnslowProject #SouthernCrossLithium #CriticalMinerals #BaseMetals #PreciousMetals #RenewableEnergyResources #ESGInitiatives #CommunityEngagement

Caprice Resources Ltd (ASX:CRS) CEO Luke Cox talked with Proactive’s Tylah Tully about the company’s ongoing exploration and development activities at its Murchison Gold Project in Western Australia.

Cox shared updates on key pillars of the company’s work: mapping quartz reefs at Cuddingwarra, resource extension drilling at the Island Gold Project, and upgrading resources at the New Orient Gold Line to JORC 2012 standards.

“We’ve identified visible gold in quartz reefs during mapping at Cuddingwarra, and we’re targeting deeper mineralisation at Island Gold using modern techniques,” Cox explained.

The Island Gold Project, which historically produced 50,000 ounces of shallow high-grade gold, holds promise for further discoveries. Meanwhile, the New Orient Gold Line resource upgrade aims to enhance its commercial potential.

In addition to the focus on gold, Caprice plans to explore its expansive West Arunta landholding in 2025, targeting rare earths, gold and copper in this underexplored region.

A geophysical survey is scheduled for March or April to kick start exploration there.

#ProactiveInvestors #CapriceResources #ASX #MurchisonGold #GoldExploration #ASXCRS #MiningUpdates #WesternAustraliaMining #RareEarths #ProactiveInvestors

Sunstone Metals Ltd (ASX:STM) managing director Patrick Duffy talked with Proactive’s Tylah Tully about the company’s key milestones achieved in 2024 and its plans for the Bramaderos and El Palmar projects in Ecuador in 2025.

Duffy outlined significant developments, including a new porphyry discovery at the Bramaderos Project’s Copete target and strong drill results at the high-grade Limon epithermal system, with a resource estimate anticipated in 2025.

At the El Palmar Project, the company announced a 1.20 million-ounce resource, complemented by an exploration target of 15 to 25 million ounces.

Duffy likened the scale of this discovery to the Boddington gold mine in Western Australia.

Leadership transitions in 2024 have been instrumental, with Duffy stepping in as managing director, Malcolm Norris transitioning to chairman and new team members Neil O’Connor and Lucas Welsh joining the board and leadership team.

Duffy also provided updates on partnership discussions aimed at securing funding to advance both major projects in 2025.

#ProactiveInvestors #SunstoneMetals #ASX #ASXSTM #BramaderosProject #ElPalmarProject #GoldExploration #MiningNews #PatrickDuffy #ProactiveStudio

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce news that the company's Investigational New Animal Drug (INAD), featuring a dissolvable doxorubicin-containing microneedle array, has been granted Minor Use in Major Species Designation or MUMS by the U.S. Food and Drug Administration. This designation marks a significant step forward for Medicus Pharma’s mission to revolutionize veterinary oncology.

The FDA's MUMS designation is a pivotal milestone, akin to the Orphan Drug status for human medicines. It offers Medicus Pharma an extended 7-year period of exclusive marketing rights following approval or conditional approval, provided the company fulfills all regulatory requirements for maintaining the designation. This exclusivity positions the company to make a profound impact on treating external squamous cell carcinoma (SCC) in horses.

The innovative doxorubicin-containing microneedle array is a patent-protected, dissolvable transdermal patch designed with cellulose-based microneedles. These microneedles are tip-loaded with doxorubicin, a potent chemotherapy agent. When applied, the microneedles penetrate the stratum corneum layer of the skin, creating temporary microchannels. This allows the microneedles to reach the tumor, dissolve, and release doxorubicin directly into the targeted area, effectively eradicating cancer cells while minimizing systemic side effects.

Squamous cell carcinoma is a significant concern in horses, particularly in adult or aged animals with white or partially white coats. Breeds such as Appaloosa, Belgian, American Paint, and Pinto are especially susceptible. SCC typically develops in areas with minimal pigmentation and sparse hair, often around mucous membranes. Commonly affected areas include the eyes, lips, nose, anus, and external genitalia. With an overall incidence rate of 2-3%, this condition impacts a notable portion of the U.S. horse population, estimated to be between 6.6 and 7.25 million horses.

#proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #CancerTreatment #HorseHealth #FDAApproval #InnovationInMedicine #SquamousCellCarcinoma #EquineCare #RazaBokhari #MUMSDesignation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ideal Power CEO Daniel Brdar joined Steve Darling from Proactive to share news announcing the company’s first design win for its innovative solid-state circuit breakers with a leading Asian circuit protection equipment manufacturer serving the industrial and utility markets.

This milestone was solidified through a joint development agreement between Ideal Power and its new partner. The collaboration involves designing, prototyping, and testing an SSCB product utilizing Ideal Power’s patented B-TRAN technology. Development is on track for completion in Q2 2025, with commercial sales expected to follow later in the year.

Brdar highlighted the revenue potential stemming from this partnership, estimating that the customer’s first B-TRAN-enabled product could generate several hundred thousand dollars in the first year alone. As adoption scales, the opportunity could surpass $1 million in revenue during the second year of sales.

The partner company has a robust, decades-long reputation for innovation and a significant foothold in the Asian market. Currently selling over 200,000 circuit breakers annually, they cater to large, established customers in sectors such as renewable energy, industrial equipment circuit protection, utility grid infrastructure, and power distribution.

The initial SSCB product will specifically target grid-tied solar and energy storage providers, as well as utility electric distribution networks, positioning Ideal Power’s B-TRAN technology as a transformative solution for modern energy systems. B-TRAN solid-state circuit breakers offer significant advantages, including higher efficiency, lower power losses, and greater reliability compared to traditional mechanical circuit breakers.

Brdar emphasized that this design win represents a pivotal step for Ideal Power, marking the first commercial application of B-TRAN in the circuit protection market.

#proactiveinvestors #idealpowerinc #nasdaq #ipwr

#BTranTechnology #SolidStateCircuitBreakers #EnergyInnovation #IndustrialTech #RenewableEnergy #ProactiveInvestors #ElectricVehicles #TechPartnerships #CleanEnergy

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Brent Charleton, President and CEO of Enwave Corporation joined Steve Darling from Proactive to announce a new partnership with ELEA Technology, a global leader in pulsed electric field technology. This agreement allows ELEA to use EnWave’s Radiant Energy Vacuum technology in combination with PEF pre-treatment to create healthier potato and vegetable snacks. The goal is to reduce or eliminate frying while maintaining superior taste, texture, and nutrition. As part of the agreement, ELEA will lease a 10kW REV™ machine at its German facility starting in February 2025 for a minimum three-month term.

Charleton emphasized that combining PEF and REV™ technologies offers significant potential to redefine snack production by delivering high-quality products with fewer unhealthy processes.

In addition to this partnership, EnWave shared strong consolidated financial results for the fourth quarter and fiscal year ending September 30, 2024. The company reported a 149% increase in Q4 revenue compared to the same period in 2023. This growth was driven by the resale of a large-scale machine and higher royalties. EnWave also achieved a 243% increase in gross margins, reflecting improved operational efficiency and growing demand for its technology.

EnWave also announced the appointment of Louise Lalonde to its Board of Directors as the new Audit Committee Chair. Lalonde, a Certified Public Accountant with over 30 years of experience in accounting, governance, and compliance, brings expertise from her tenure at Price Waterhouse Coopers and leadership roles in manufacturing and service sectors. Her appointment follows the retirement of current Audit Committee Chair Mary Ritchie, who was recognized for her valuable contributions to the company.

#proactiveinvestors #enwavecorporation #tsxv #enw #DehydrationTech #VacuumMicrowave #RoyaltyBusinessModel #BluechipClients #MilitaryContracts #FoodIndustryInnovation #ShelfStableRations #GlobalExpansion #USArmy

#HealthierSnacks #ELEATechnology #FoodInnovation #REVTechnology #FinancialGrowth #HealthyEating #CEOInterview #InvestingInTech #SnackRevolution

#investing #investment #investor #stockmarket #stocks #stock #stockmarketnews